| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/AJRCCM.156.1.9607066 |
| P698 | PubMed publication ID | 9230753 |
| P2093 | author name string | Li X | |
| Wilson JW | |||
| P433 | issue | 1 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 229-233 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Increased vascularity of the bronchial mucosa in mild asthma | |
| P478 | volume | 156 |
| Q38007092 | A friend to the airways: a review of the emerging clinical importance of the bronchial arterial circulation. |
| Q36086891 | Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma |
| Q37353726 | Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling |
| Q33731149 | Airway remodeling and persistent airway obstruction in asthma |
| Q34567505 | Airway remodeling in the pathogenesis of asthma |
| Q37875805 | Airway remodeling: a potential therapeutic target in asthma |
| Q34105688 | Airway remodelling in asthma: from benchside to clinical practice |
| Q38048279 | Airway smooth muscle as a target in asthma and the beneficial effects of bronchial thermoplasty |
| Q77751348 | Airway vascular changes in lung allograft recipients |
| Q35058272 | Airway vascular remodeling in asthma |
| Q33774598 | Allergen-induced, eotaxin-rich, proangiogenic bone marrow progenitors: a blood-borne cellular envoy for lung eosinophilia |
| Q43087568 | Angiogenesis and airway reactivity in asthmatic Brown Norway rats |
| Q36758867 | Angiogenesis in chronic lung disease |
| Q35753515 | Angiogenesis in mice with chronic airway inflammation: strain-dependent differences |
| Q34958415 | Angiogenesis in paediatric airway disease |
| Q43226022 | Angiogenesis in the ischemic rat lung |
| Q90325135 | Angiogenesis in the lung |
| Q24805418 | Angiogenesis in the pathogenesis of inflammatory joint and lung diseases |
| Q33668427 | Angioplasticity in asthma |
| Q39745485 | Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation |
| Q36001230 | Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics |
| Q37541992 | Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat. |
| Q37198561 | Aortopulmonary collateral flow in cystic fibrosis assessed with phase-contrast MRI. |
| Q36282984 | Are mouse models of asthma appropriate for investigating the pathogenesis of airway hyper-responsiveness? |
| Q93038051 | Arginine metabolic control of airway inflammation |
| Q90477752 | As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say? |
| Q37321890 | Association of vascular endothelial growth factor polymorphisms with asthma in Tunisian children. |
| Q34074326 | Biopsy markers of airway inflammation and remodelling |
| Q28507417 | Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice |
| Q37380192 | Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice |
| Q41517954 | Changes of plasmalogen phospholipid levels during differentiation of induced pluripotent stem cells 409B2 to endothelial phenotype cells |
| Q34776671 | Chemokine localization in bronchial angiogenesis |
| Q42318013 | Clinical significance of serum vascular endothelial growth factor in young male asthma patients |
| Q35633317 | Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome |
| Q26796418 | Complement mediators: key regulators of airway tissue remodeling in asthma |
| Q33977282 | Consequences of long-term inflammation. Airway remodeling |
| Q24799958 | Correlation of exhaled breath temperature with bronchial blood flow in asthma |
| Q33717312 | Cytokines in asthma |
| Q54528175 | Depletion of CD8+ T cells enhances airway remodelling in a rodent model of asthma. |
| Q36302003 | Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease |
| Q90174208 | Effect of C1-inhibitor in adults with mild asthma: A randomized controlled trial |
| Q40602423 | Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma |
| Q37318196 | Effects of the menstrual cycle on lung function variables in women with asthma |
| Q28069363 | Endocan and the respiratory system: a review |
| Q35939655 | Endoscopic Evaluation of Angiogenesis in the Large Airways of Horses with Heaves Using Narrow Band Imaging |
| Q89134553 | Endothelial cells in the innate response to allergens and initiation of atopic asthma |
| Q36601063 | Eotaxin-Rich Proangiogenic Hematopoietic Progenitor Cells and CCR3+ Endothelium in the Atopic Asthmatic Response. |
| Q38507471 | Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients |
| Q37747204 | Fatty Acid Binding Protein 11a Is Required for Brain Vessel Integrity in Zebrafish |
| Q30413957 | Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma |
| Q34429022 | IFN-γ and TNF-α synergize to inhibit CTGF expression in human lung endothelial cells |
| Q35323302 | IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model |
| Q44301749 | Identification of novel genetic regulations associated with airway epithelial homeostasis using next-generation sequencing data and bioinformatics approaches. |
| Q50348165 | IgE mediates broncho-vascular remodeling after neonatal sensitization in mice. |
| Q35878513 | Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling |
| Q51819888 | Increased Airway Vascularity in Newly Diagnosed Asthma Using a High-magnification Bronchovideoscope |
| Q43179296 | Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype |
| Q35534851 | Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients |
| Q41874365 | LF-15 & T7, synthetic peptides derived from tumstatin, attenuate aspects of airway remodelling in a murine model of chronic OVA-induced allergic airway disease |
| Q92320973 | Longitudinal changes in structural lung abnormalities using MDCT in chronic obstructive pulmonary disease with asthma-like features |
| Q35816474 | Lung Angiogenesis Requires CD4(+) Forkhead Homeobox Protein-3(+) Regulatory T Cells |
| Q34598523 | Lung and vascular function during chronic severe pulmonary ischemia |
| Q35235823 | Lung gene expression in a rhesus allergic asthma model correlates with physiologic parameters of disease and exhibits common and distinct pathways with human asthma and a mouse asthma model |
| Q39263241 | Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung? |
| Q37187005 | Markers of vascular perturbation correlate with airway structural change in asthma |
| Q35672026 | Matrix stiffness-modulated proliferation and secretory function of the airway smooth muscle cells |
| Q39655373 | Mechanisms of remodeling in asthmatic airways |
| Q91993914 | Multi-Faceted Notch in Allergic Airway Inflammation |
| Q35583036 | Nasal involvement in allergic asthma |
| Q81431323 | Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression |
| Q33708722 | Neutrophil dependence of vascular remodeling after Mycoplasma infection of mouse airways |
| Q55401303 | New targets for resolution of airway remodeling in obstructive lung diseases. |
| Q52337419 | PTEN gene silencing contributes to airway remodeling and induces airway smooth muscle cell proliferation in mice with allergic asthma. |
| Q34336241 | Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques. |
| Q24678822 | Pharmacotherapy and airway remodelling in asthma? |
| Q36013653 | Plasminogen is an important regulator in the pathogenesis of a murine model of asthma |
| Q34320684 | Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes |
| Q37907120 | Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation |
| Q88407213 | Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort |
| Q38206113 | Pulmonary vasculature and critical asthma syndromes: a comprehensive review |
| Q35534318 | Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects |
| Q33668491 | Redox control of asthma: molecular mechanisms and therapeutic opportunities |
| Q36478639 | Remodeling of extra-bronchial lung vasculature following allergic airway inflammation |
| Q41956918 | Repeated challenge with dinitrobenzene sulphonic acid in dinitrofluorobenzene-sensitized mice results in vascular hyperpermeability in the trachea: a role for tachykinins |
| Q36796418 | Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2. |
| Q37082574 | Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. |
| Q36287476 | Role of human mast cells and basophils in bronchial asthma |
| Q34539102 | Serum angiopoietin is associated with lung function in patients with asthma: a retrospective cohort study |
| Q34533661 | T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma |
| Q36919220 | The Effects of Tumstatin on Vascularity, Airway Inflammation and Lung Function in an Experimental Sheep Model of Chronic Asthma |
| Q42129392 | The SDF-1α3'A genetic variation is correlated with susceptibility of asthma in Iranian patients |
| Q35763560 | The Three A's in Asthma - Airway Smooth Muscle, Airway Remodeling & Angiogenesis |
| Q34074333 | The anti-inflammatory profile of inhaled corticosteroids combined with salmeterol in asthmatic patients |
| Q73144652 | The anti-inflammatory profile of inhaled corticosteroids: biopsy studies in asthmatic patients |
| Q42138465 | The effect of interleukin-4 and amphiregulin on the proliferation of human airway smooth muscle cells and cytokine release |
| Q34618287 | The expression and activity of cathepsins D, H and K in asthmatic airways. |
| Q38055384 | The pharmacological modulation of allergen-induced asthma. |
| Q37797577 | The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. |
| Q39094033 | The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD). |
| Q37761773 | The role of viruses in acute exacerbations of asthma |
| Q36438085 | Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo |
| Q35172753 | Transforming growth factor-beta and its role in asthma |
| Q34453206 | Understanding airway wall remodeling in asthma: a basis for improvements in therapy? |
| Q37072079 | Understanding the mechanisms of viral induced asthma: new therapeutic directions |
| Q44240285 | Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone |
| Q36209876 | Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. |
| Q38053080 | Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways |
| Q37110304 | Vascular remodeling is airway generation-specific in a primate model of chronic asthma |
| Q35533103 | Vascularity in asthmatic airways: relation to inhaled steroid dose |
| Q34328236 | Vessel-associated transforming growth factor-beta1 (TGF-β1) is increased in the bronchial reticular basement membrane in COPD and normal smokers |
| Q33773550 | Why is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthma |
| Q77565947 | [Asthma. Seven current questions] |
| Q80229203 | [Nerve growth factor (NGF) in inflammation and asthma] |
Search more.